CPT code 67220 denotes laser photocoagulation directed at a localized choroidal lesion to ablate abnormal blood vessel growth in the vascular layer of the eye. This procedure is an established ophthalmic treatment for focal choroidal neovascularization and other localized choroidal abnormalities that pose a risk to visual function. Nationally, accurate coding for this intervention impacts clinical tracking, reimbursement, and utilization monitoring for retinal and choroidal disease therapies. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical intent of the code, typical sites of service, and the service type. The publication also summarizes payer coverage patterns and benchmark considerations, outlines common billing modifiers, and situates the code within ophthalmic procedural coding practice. Clinical context explains when laser photocoagulation of the choroid is used relative to other retinal therapies. Policy implications address coding specificity and documentation elements that commonly affect claim adjudication. Data limitations and missing elements from the input are identified where applicable. The briefing is intended for clinicians, billing professionals, and policy analysts seeking a practical, national-level summary of CPT code 67220.